Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
   
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Pathways
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Stockholm: There Is No Spatial Paradox!
1 August 2002. In a wide-ranging and eloquent presentation at the 8th International Conference on Alzheimer’s Disease and Related Disorders held last week in Stockholm, Christian Haass (Abstract 1059) provided several experimental proofs that a small amount of presenilin is detected at the plasma membrane. Using a relatively new technique, total internal reflection microscopy (TIRM) Haass demonstrated that exogenous GFP-tagged PS could readily be detected in the endoplasmic reticulum and also on the plasma membrane. Furthermore, he was able to biotinylate mature Nicastrin on the plasma membrane and then in co-immunoprecipitation experiments he detected endogenous PS heterodimers associated with the biotinylated Nicastrin, thus indicating that two essential components of the γ-secretase complex, namely PS and Nicastrin, are detected together at the cell surface. Based on these experiments, Haass estimated that approximately one-thirtieth of total cellular PS was localized to the plasma membrane.

Haass also presented data demonstrating that Notch and CD44 are cleaved in a PS-dependent manner at a γ-site in the middle of the transmembrane domain at a position equivalent to cleavage after residue 40 of the A β sequence. This cleavage, which he termed site 4 (S4), gives rise to a p3-like, soluble peptide of both Notch and CD44. In addition, he also reported on the well-characterized site 3 (S3) cleavage of Notch detecting a secreted peptide Mass ~4358 consistent with proteolysis just 3 amino acid residues into the transmembrane sequence.

Finally, Haass reviewed data that AβPP was cleaved at a position similar to the Notch S3, aka the ε site, and that familial Alzheimer's disease mutations in PS cause an increase in γ-cleaved APP and Notch and a decrease in ε cleavage. This latter point was corroborated by another speaker, Peter St. George-Hyslop and further suggests that increased production of Aβ is the initiating event in AD pathogenesis as opposed to transcriptional deregulation mediated by an increase in functional AICD generation.

From the data presented it is not possible to determine whether cleavage at the γ and ε sites occur sequentially or simultaneously. In addition to the products discussed above, APPC59, AAβ49 and the 9 amino acid peptide spanning the γ and ε cleavage sites have yet to be detected. Only when these fragments and their temporal production is uncovered will it be possible to determine the order of the γ and ε cleavages.—Dominic Walsh.

 
Comments on Related News
  Related News: Erene Mina Reports on Presenilin’s Loops through the Membrane

Comment by:  Michael Wolfe, ARF Advisor
Submitted 23 January 2004 Posted 23 January 2004

This paper revisits the issue of presenilin topology, providing further evidence of a 7-TM model with an orientation opposite those suggested from many other studies. With new antibodies in hand, Dewji and colleagues detected the PS1 N-terminus and a large internal loop as being outside the cell by immunofluorescent techniques. In contrast, the C-terminus was not detected, suggesting that this region is intracellular and that PS has an odd number of TM domains. The study included endogenous PS1, avoiding possible artifacts as a consequence of tagging or overexpression. However, there are caveats.

The failure to detect the C-terminus outside the cell using antibodies means only that this domain was not detected outside the cell using antibodies. The C-terminus is well-known from mutagenesis studies to be essential for PS function. Moreover, while immunoprecipitation with antibodies to the PS1 N-terminus brings down nicastrin, Aph-1, and Pen-1 as well as γ-secretase activity, antibodies to the C-terminus do not, suggesting that the C-terminus is unavailable for interaction...  Read more


  Related News: Erene Mina Reports on Presenilin’s Loops through the Membrane

Comment by:  Fred Van Leuven (Disclosure)
Submitted 26 January 2004 Posted 26 January 2004

That PS1 keeps a most amazing profile is no longer a surprise, but the results reported now by J. Singer and colleagues will certainly invigorate the debate about the "firmness" of some concepts.

First, let's recall the data of this same group demonstrating PS1 at the cell-surface back in 1997. It seemed unbelievable and was not believed—and played into the concept of the "spatial paradox." This imaginary or virtual concept was never based on very hard data, so not surprisingly, it turned out to be untenable. That PS1 is (or can be) located in "all" cellular compartments, directed there by its molecular partners (nicastrin, APH2, Pen1...) and even by some of its (many) substrates, is now accepted and underscored by experimental data.

We have developed the idea that PS1 and γ-secretase (to us, both names equate to the same active entity) is actually "a-channel-turned-proteinase" (Dewachter et al., 2001). The topology, however interesting it is, has not been our major concern, as we focus on the...  Read more


  Related News: Erene Mina Reports on Presenilin’s Loops through the Membrane

Comment by:  Nazneen Dewji
Submitted 3 February 2004 Posted 8 February 2004
  I recommend the Primary Papers

By this date, three comments followed the on-line publication of our paper in the Proc. Natl. Acad. Sci. USA (1). The one by Erene Mina was a brief review of our paper; the second consisted of some interesting comments on PS and ß-APP by Fred Van Leuven; and the third by Michael Wolfe. We consider here only the last one, since it is the only one critical of our conclusion that the PS molecule has a 7-transmembrane (7-TM) topology in the surface membranes of cells, and not the 8-TM that is currently widely accepted. Dr. Wolfe argues that there is a great deal of evidence that has been adduced to support the 8-TM model, and therefore that the 7-TM model, which is apparently inconsistent with this data, cannot be correct. We do not think that the number of publications supporting one or the other model is a criterion by which to judge which one is correct. Rather, it is the inability to find an experimental or logical fault with a particular piece or set of evidence supporting a conclusion. In this respect, Dr. Wolfe does not refer to any significant fault with our data or...  Read more
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password  
*Confirm Password  
Remember my Login and Password?  

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Follow on Twitter
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2010 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad